All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Regeneron Pharmaceuticals, Inc. earnings schedule

Regeneron Pharmaceuticals, Inc. quarterly earnings, REGN earnings report for 2020. When does Regeneron Pharmaceuticals, Inc. report earnings?
Add to widgets
Added to widgets

When does Regeneron Pharmaceuticals, Inc. report earnings?

Regeneron Pharmaceuticals, Inc. reports earnings every quartal, last Regeneron Pharmaceuticals, Inc. earnings report date was 31/12/2019.

How much is Regeneron Pharmaceuticals, Inc. earnings per share?

Regeneron Pharmaceuticals, Inc. estimated earnings per share was 7.5 $ last time.

When is Regeneron Pharmaceuticals, Inc. next earnings report?

Next Regeneron Pharmaceuticals, Inc. earnings call will be in March 2021.

Regeneron Pharmaceuticals, Inc. earnings per share - the financial characteristics of the company on the size of its value. Earnings per share is calculated simply - all the company's profit for the reporting financial period divided by the number of shares. It is clear that Regeneron Pharmaceuticals, Inc. earnings per share is a financial characteristic for a certain period. Profit of Regeneron Pharmaceuticals, Inc. - the entire profit of the company in the reporting period.

Show:
to

Regeneron Pharmaceuticals, Inc. earnings report

Regeneron Pharmaceuticals, Inc. total profit is for reference only and is not interesting to individual shareholders. A much more interesting indicator is earnings per share, which directly affects the amount of dividends per share. The date of the profit report Regeneron Pharmaceuticals, Inc. is tied to the legislation of the country of registration of the company. All dates of Regeneron Pharmaceuticals, Inc. profit reports are shown in our schedule and our table.

Regeneron Pharmaceuticals, Inc. quarterly earnings

Earnings per share Regeneron Pharmaceuticals, Inc. is calculated by dividing net income by the number of shares in the company. Earnings per share Regeneron Pharmaceuticals, Inc. is an indicator of a certain financial interval. It is easy to guess that the financial period coincides with the publication of financial statements of profit. Regeneron Pharmaceuticals, Inc. earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Quarterly profit Regeneron Pharmaceuticals, Inc. is the main type of financial statements among companies.

REGN earnings date Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
Change for a year %
31/12/2019 7.5 USD +23.6% ↑
30/09/2019 6.67 USD +23.9% ↑
30/06/2019 6.02 USD +15.2% ↑
31/03/2019 4.45 USD +25.67% ↑
31/12/2018 6.84 USD +23.67% ↑
30/09/2018 5.87 USD +33.36% ↑
30/06/2018 5.45 USD +48.26% ↑
31/03/2018 4.67 USD +42.19% ↑
31/12/2017 5.23 USD +49.53% ↑
30/09/2017 3.99 USD +42.21% ↑
30/06/2017 4.17 USD +19.56% ↑
31/03/2017 2.92 USD +18.6% ↑
31/12/2016 3.04 USD -10.934% ↓
30/09/2016 3.13 USD -18.0598% ↓
30/06/2016 2.82 USD -4.6082% ↓
31/03/2016 2.57 USD -3.929% ↓
31/12/2015 2.83 USD +19.27% ↑
30/09/2015 3.47 USD +24.15% ↑
30/06/2015 2.89 USD +20.76% ↑
31/03/2015 2.88 USD +21.93% ↑
31/12/2014 2.79 USD +186.59% ↑
30/09/2014 2.52 USD +184.61% ↑
30/06/2014 2.47 USD +161.62% ↑
31/03/2014 2.26 USD +124.92% ↑
31/12/2013 0.86 USD -11.887% ↓
30/09/2013 1.25 USD -4.49% ↓
30/06/2013 0.79 USD +229.25% ↑
31/03/2013 0.9 USD -525.274% ↓
31/12/2012 1.22 USD -283.005% ↓
30/09/2012 1.72 USD -224.67% ↓
30/06/2012 0.7 USD -165.249% ↓
31/03/2012 0.16 USD -35.754% ↓
31/12/2011 -0.54 USD -46.397% ↓
30/09/2011 -0.68 USD -55.541% ↓
30/06/2011 -0.69 USD -8.163% ↓
31/03/2011 -0.49 USD -27.125% ↓
31/12/2010 -0.17 USD -4.041% ↓
30/09/2010 -0.41 USD -40.356% ↓
30/06/2010 -0.31 USD -24.533% ↓
31/03/2010 -0.38 USD -37.15% ↓
31/12/2009 -0.46 USD -10.266% ↓
30/09/2009 -0.01 USD -36.693% ↓
30/06/2009 -0.19 USD -7.213% ↓
31/03/2009 -0.22 USD -4.792% ↓
31/12/2008 -0.4 USD -36.514% ↓
30/09/2008 -0.27 USD -5.0614% ↓
30/06/2008 -0.23 USD -28.793% ↓
31/03/2008 -0.15 USD -34.619% ↓
31/12/2007 -0.19 USD -6.74% ↓
30/09/2007 -0.54 USD -46.365% ↓
30/06/2007 -0.41 USD -24.189% ↓
31/03/2007 -0.46 USD -19.13% ↓
31/12/2006 -0.51 USD -22.237% ↓
30/09/2006 -0.48 USD -5.28% ↓
30/06/2006 -0.41 USD -8.85% ↓
31/03/2006 -0.36 USD -55% ↓
31/12/2005 -0.53 USD -44.648% ↓
30/09/2005 -0.52 USD -33.258% ↓
30/06/2005 -0.38 USD -41.101% ↓
31/03/2005 -0.07 USD -36.307% ↓
31/12/2004 0.05 USD -31.698% ↓
30/09/2004 -0.2 USD -24.571% ↓
30/06/2004 -0.26 USD -45.346% ↓
31/03/2004 1.06 USD -48.718% ↓
31/12/2003 -0.35 USD -37.463% ↓
30/09/2003 -0.52 USD -32.692% ↓
30/06/2003 -0.58 USD -12.941% ↓
31/03/2003 -0.68 USD -26.331% ↓
31/12/2002 -0.81 USD -
30/09/2002 -0.75 USD -
30/06/2002 -0.69 USD -
31/03/2002 -0.58 USD -

Regeneron Pharmaceuticals, Inc. quarterly earnings per share is also one of the organization’s profitability indicators, although less popular than annual earnings per share. Last quarterly profit Regeneron Pharmaceuticals, Inc. for today implies published profit for the last reference quarter. The change in profit of Regeneron Pharmaceuticals, Inc. for the year is calculated in comparison with the same financial period as the current indicator only for the previous year. The change in quarterly profit of Regeneron Pharmaceuticals, Inc. is a less significant value relative to the change in annual profit of Regeneron Pharmaceuticals, Inc..

For convenience of perception and analysis, we publish the change in profit as a percentage. The profit history of Regeneron Pharmaceuticals, Inc. for previous years is given in our table “Quarterly profit”. Regeneron Pharmaceuticals, Inc. quarterly earnings history is available online for each year and quarter over the past ten years. Regeneron Pharmaceuticals, Inc. online profit database for past time intervals is compiled from verified official sources throughout the entire time.

Regeneron Pharmaceuticals, Inc. stocks data

Regeneron Pharmaceuticals, Inc. financials